Surgery for lung cancer: insight from a state cancer centre in India.

Pub Date : 2024-01-01 Epub Date: 2023-09-04 DOI:10.1007/s12055-023-01590-9

Mohamed Taher Mithi, Mohit Sharma, Ketul Puj, Jebin Aaron Devarajan, Nilang Joshi, Shashank J Pandya, Shailesh Patel, Vikas Warikoo, Priyank Rathod, Shivam Pandya, Abhijeet Salunke, Keval Patel, Vasudha Garg

{"title":"Surgery for lung cancer: insight from a state cancer centre in India.","authors":"Mohamed Taher Mithi, Mohit Sharma, Ketul Puj, Jebin Aaron Devarajan, Nilang Joshi, Shashank J Pandya, Shailesh Patel, Vikas Warikoo, Priyank Rathod, Shivam Pandya, Abhijeet Salunke, Keval Patel, Vasudha Garg","doi":"10.1007/s12055-023-01590-9","DOIUrl":null,"url":null,"abstract":"Purpose: Lung cancer is one of the most common cancers in India. However, less than half receive treatment with a curative intent and very few undergo surgery amongst them. We present our surgical experience with non-small cell lung cancer.Methods: A retrospective analysis of a cohort of 92 non-small cell lung cancer patients operated with curative intent.Results: Less than 2% patients of lung cancer were operated on at our centre. Adenocarcinoma was the most common histological subtype. Right upper lobectomy was the most common surgery performed. Two- and 3-year overall survival was 74.3% and 70.6% respectively. Two- and 3- year disease-free survival was 65.4% and 60.8% respectively.Conclusion: The fraction of patients who are operated for lung cancer is very less. There is a definite missed window of opportunity. We have comparable survival to international data.","PeriodicalId":0,"journal":{"name":"","volume":" ","pages":"50-57"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728424/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12055-023-01590-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Lung cancer is one of the most common cancers in India. However, less than half receive treatment with a curative intent and very few undergo surgery amongst them. We present our surgical experience with non-small cell lung cancer.

Methods: A retrospective analysis of a cohort of 92 non-small cell lung cancer patients operated with curative intent.

Results: Less than 2% patients of lung cancer were operated on at our centre. Adenocarcinoma was the most common histological subtype. Right upper lobectomy was the most common surgery performed. Two- and 3-year overall survival was 74.3% and 70.6% respectively. Two- and 3- year disease-free survival was 65.4% and 60.8% respectively.

Conclusion: The fraction of patients who are operated for lung cancer is very less. There is a definite missed window of opportunity. We have comparable survival to international data.

查看原文

微信好友朋友圈 QQ好友复制链接

肺癌手术:来自印度国家癌症中心的见解

目的：肺癌是印度最常见的癌症之一。然而，只有不到一半的患者接受了根治性治疗，其中接受手术治疗的患者更是寥寥无几。我们将介绍非小细胞肺癌的手术经验：方法：对 92 例以治愈为目的进行手术的非小细胞肺癌患者进行回顾性分析：在我们中心接受手术的肺癌患者不到2%。腺癌是最常见的组织学亚型。右上肺叶切除术是最常见的手术。两年和三年总生存率分别为74.3%和70.6%。两年和三年无病生存率分别为65.4%和60.8%：结论：肺癌患者接受手术的比例非常低。结论：肺癌患者接受手术治疗的比例非常低，这无疑错失了良机。我们的生存率与国际数据相当。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助